Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5007 USD | +6.13% |
|
+0.04% | -52.33% |
05-28 | Evoke Pharma, Inc. Appoints Mark A. Kowieski as Chief Financial Officer | CI |
05-14 | Evoke Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-52.33% | 4.06M | |
+51.71% | 823B | |
+40.34% | 641B | |
-6.39% | 352B | |
+16.58% | 324B | |
+7.93% | 301B | |
+14.04% | 241B | |
+1.76% | 223B | |
+13.24% | 218B | |
+7.12% | 167B |
- Stock Market
- Equities
- EVOK Stock
- News Evoke Pharma, Inc.
- Evoke Pharma Says FDA Lists Latest US Patent for Gimoti in Orange Book